Analystreport

Integra LifeSciences Holdings Corporation (NASDAQ: IART) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.

Integra LifeSciences Holdings Corporation  (IART) 
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.integralife.com